Harter, P., Mahner, S., Hilpert, F., Runnebaum, I., Ortmann, O., Mustea, A., . . . Wagner, U. (2013). Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. Georg Thieme Verlag KG.

Harter, P., S. Mahner, F. Hilpert, I. Runnebaum, O. Ortmann, A. Mustea, J. Sehouli, A. du Bois, and U. Wagner. Statement By the Kommission OVAR of the AGO Study Group On the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. Georg Thieme Verlag KG, 2013.

Harter, P., et al. Statement By the Kommission OVAR of the AGO Study Group On the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. Georg Thieme Verlag KG, 2013.